Last update 20 Mar 2025

Human Rabies Immunoglobulin (Weiguang Biological)

Overview

Basic Info

Drug Type
Immunoglobulin
Synonyms-
Target-
Action
stimulants
Mechanism
Immunostimulants
Therapeutic Areas
Infectious DiseasesOther Diseases
Active Indication
Rabies
Inactive Indication-
Originator Organization
Shenzhen Weiguang Biological Products Co., Ltd.Shenzhen Weiguang Biological Products Co., Ltd.
Active Organization
Shenzhen Weiguang Biological Products Co., Ltd.Shenzhen Weiguang Biological Products Co., Ltd.
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
China (01 Jan 2003),
Rabies
Regulation-
Login to view timeline

Related

100 Clinical Results associated with Human Rabies Immunoglobulin (Weiguang Biological)
Login to view more data
100 Translational Medicine associated with Human Rabies Immunoglobulin (Weiguang Biological)
Login to view more data
100 Patents (Medical) associated with Human Rabies Immunoglobulin (Weiguang Biological)
Login to view more data
3
Literatures (Medical) associated with Human Rabies Immunoglobulin (Weiguang Biological)
01 Oct 2003Therapeutische Umschau
Viren ohne Grenzen – Tollwutrisiko auf Reisen
01 Jan 1973Monograph series. World Health Organization
Preparation of antirabies immunoglobulin of human origin.
Acta Médica Portuguesa
Raiva Humana: Optimização da Prevenção e Caminhos Para a Cura
100 Deals associated with Human Rabies Immunoglobulin (Weiguang Biological)
Login to view more data

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Rabies
China
Shenzhen Weiguang Biological Products Co., Ltd.Shenzhen Weiguang Biological Products Co., Ltd.
01 Jan 2003
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free